is retatrutide fda approved october 2025 What Tirzepatide Used for? and Potential Uses GLP-1 Pipeline Update: November 2025
Description
Fatigue and dizziness , particularly in the early weeks of treatment
GLP-1RAs have shown some neuroprotective effects in rodents with neurogenerative diseases (65)
However, after this initial rebound, switching to subcutaneous semaglutide would be expected to result in additional reductions in A1C and weight compared with the other GLP-1 receptor agonists (60)
*Based on clinical trials
This personalized approach ensures you reach an effective dose without unnecessary discomfort
But I was also losing my hair in terrifying amounts
